Pubblicazioni

Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial

2021 - THE LANCET. HAEMATOLOGY

Ladetto, M.; Cortelazzo, S.; Ferrero, S.; Evangelista, A.; Mian, M.; Tavarozzi, R.; Zanni, M.; Cavallo, F.; Di Rocco, A.; Stefoni, V.; Pagani, C.; Re, A.; Chiappella, A.; Balzarotti, M.; Zilioli, V. R.; Gomes da Silva, M.; Arcaini, L.; Molinari, A. L.; Ballerini, F.; Ferreri, A. J. M.; Puccini, B.; Benedetti, F.; Stefani, P. M.; Narni, F.; Casaroli, I.; Stelitano, C.; Ciccone, G.; Vitolo, U.; Martelli, M.

Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT

2021 - EUROPEAN JOURNAL OF HAEMATOLOGY

Garderet, L; Sbianchi, G; Iacobelli, S; Blaise, D; Byrne, Jl; Remenyi, P; Apperley, Jf; Touzeau, C; Isaksson, C; Browne, P; Mayer, J; Lenhoff, S; Muniz, Sg; Porras, Rp; Basak, G; Poire, X; Trneny, M; Nagler, A; Michieli, M; Tanase, A; Koster, L; Hayden, Pj; Beksac, M; Schonland, S; Yakoub-Agha, I